| (210) | Number of the EPO application | 19749096 |
| (220) | Filing date of the EPO application | 2019.07.18 |
| (80) | EPO patent specification publication (B) | EPB nr. 02/2025, 2025.01.08 |
| (110) | EPO patent number | 3823664 |
| (21) | Number of the application | e 2021 0483 |
| (71) | Name(s) of applicant(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | SMITH Eric, US;
OLSON Kara, US;
DELFINO Frank, US;
DILILLO David, US;
KIRSHNER Jessica, US;
SINESHCHEKOVA Olga, US;
ZHANG Qian, US; |
| (73) | Name(s) of owner(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (54) | Title of the invention | Bispecific anti-bcma x anti-cd3 antibodies and uses thereof |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/00 (2006.01.01); A61P 35/02 (2006.01.01); C07K 16/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.06.30 |
| (30) | Priority | 201862700596 P, 2018.07.19, US; 201862750968 P, 2018.10.26, US; 201962793645 P, 2019.01.17, US |
| (74) | Patent attorney | (Procedură) JENICICOVSCAIA Galina, Str. Miron Costin nr. 15/2, of. 19-20, MD-2045, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2019/042447, 2019.07.18 |
| (87) | International publication | WO 2020/018820, 2020.01.23 |